Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation: Cardiovascular Interventions
Search: search_blue_button Advanced Search
Circulation: Cardiovascular Interventions. 2008;1:209-216
doi: 10.1161/CIRCINTERVENTIONS.108.830018
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reddy, M. K.
Right arrow Articles by Labhasetwar, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reddy, M. K.
Right arrow Articles by Labhasetwar, V.
Related Collections
Right arrow Catheter-based coronary and valvular interventions: other
Right arrow Restenosis
Right arrowRelated Article

Original Articles

Inhibition of Apoptosis Through Localized Delivery of Rapamycin-Loaded Nanoparticles Prevented Neointimal Hyperplasia and Reendothelialized Injured Artery

Maram K. Reddy, PhD; Jaspreet K. Vasir, PhD; Sanjeeb K. Sahoo, PhD; Tapan K. Jain, PhD; Murali M. Yallapu, PhD and Vinod Labhasetwar, PhD

From the Department of Biomedical Engineering (M.K.R., J.K.V., T.K.J., M.M.Y., V.L.), Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio; and the Department of Pharmaceutical Sciences (J.K.V., S.K.S., V.L.), College of Pharmacy, University of Nebraska Medical Center, Omaha, Neb.

Correspondence to Vinod Labhasetwar, PhD, Department of Biomedical Engineering/ND20, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195. E-mail labhasv{at}ccf.org

Received July 21, 2008; accepted October 24, 2008.

Background— A significant fraction of vascular smooth muscle cells (VSMCs) undergo rapid apoptosis after balloon angioplasty. In this study, we tested the hypothesis that protecting VSMCs from undergoing apoptosis prevents the cascade of events that lead to intimal hyperplasia.

Methods and Results— Rapamycin-loaded gel-like nanoparticles (mean diameter, 54±5 nm) were infused locally in a rat carotid artery model of vascular injury. The drug has both antiapoptotic and antiproliferative effects on VSMCs and hence was selected for the current study. Localized delivery of nanoparticles sustained the drug level in the target artery for >2 weeks; demonstrated significant inhibition of hyperplasia (intima/media ratio, 1.5±0.02 versus 2.7±0.6; P<0.01); and most importantly, reendothelialized the injured artery (endothelium coverage: treated 82% versus control 28%). We also demonstrated inhibition of activation of caspase-3/7 enzymes in the treated artery, preventing VSMCs from undergoing apoptosis and subsequent infiltration of macrophages.

Conclusions— It may be postulated that the localized delivery of rapamycin inhibited apoptosis of VSMCs, minimizing the inflammatory response to the injury and, thus, creating conditions conducive to vascular repair (reendothelialization). Unlike stenting, which can lead to thrombosis and increased risk for in-stent restenosis, our approach could eliminate or minimize long-term complications because the injured artery undergoes a natural process of reendothelialization.

Key Words: catheterization • endothelium • restenosis • apoptosis • nanoparticles


 

CLINICAL PERSPECTIVE


Related Article

Inhibition of Apoptosis Through Localized Delivery of Rapamycin-Loaded Nanoparticles Prevented Neointimal Hyperplasia and Reendothelialized Injured Artery
Maram K. Reddy, Jaspreet K. Vasir, Sanjeeb K. Sahoo, Tapan K. Jain, Murali M. Yallapu, and Vinod Labhasetwar
Circ Cardiovasc Interv 2008 1: 209-216. [Abstract] [Full Text] [PDF]